No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1xuoA, 1.0000, 0.00, 1.000, 181, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
2, 3bqmC, 0.9802, 0.96, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
3, 1xddA, 0.9800, 1.00, 1.000, 182, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
4, 3bqnC, 0.9798, 0.97, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
5, 3bqmB, 0.9794, 0.98, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
6, 3bqnB, 0.9788, 0.99, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
7, 3e2mB, 0.9786, 1.00, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
8, 1xdgB, 0.9784, 1.11, 1.000, 182, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
9, 1zopA, 0.9783, 1.01, 0.989, 183, 181, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
10, 1zooA, 0.9783, 1.01, 0.989, 183, 181, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
11, 1xdgA, 0.9780, 1.11, 0.994, 182, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
12, 1cqpA, 0.9779, 1.10, 0.994, 182, 181, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
13, 1zopB, 0.9778, 1.03, 0.989, 183, 181, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
14, 1zooB, 0.9778, 1.03, 0.989, 183, 181, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
15, 3e2mA, 0.9774, 1.00, 0.994, 182, 181, LFA-1 I DOMAIN BOUND TO INHIBITORS
16, 1xddB, 0.9771, 1.07, 1.000, 182, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
17, 1rd4C, 0.9771, 1.04, 0.994, 184, 181, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
18, 1rd4B, 0.9771, 1.04, 0.989, 184, 181, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
19, 1rd4D, 0.9770, 1.04, 0.989, 184, 181, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
20, 1rd4A, 0.9770, 1.04, 0.989, 184, 181, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
21, 1lfaB, 0.9765, 1.06, 0.994, 182, 181, CD11A I-DOMAIN WITH BOUND MN++
22, 1lfaA, 0.9764, 1.03, 0.989, 183, 181, CD11A I-DOMAIN WITH BOUND MN++
23, 1cqpB, 0.9759, 1.13, 1.000, 182, 181, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
24, 4ixdA, 0.9756, 1.05, 0.994, 182, 181, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION
25, 3eoaI, 0.9742, 0.69, 0.989, 179, 179, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
26, 3eoaJ, 0.9738, 0.71, 0.989, 179, 179, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
27, 3m6fA, 0.9732, 0.85, 0.978, 180, 180, CD11A I-DOMAIN COMPLEXED WITH 6-((5S9R)-9-(4-CYANOPHENYL)-3-(35- DICHLOROPHENYL)-1-METHYL-24-DIOXO-137- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID
28, 3eobJ, 0.9732, 0.73, 0.989, 179, 179, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
29, 3eobI, 0.9721, 0.76, 0.989, 179, 179, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
30, 2icaA, 0.9716, 0.72, 0.983, 179, 179, CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S 9R)-9-(4-CYANOPHENYL)-3-(35-DICHLOROPHENYL)-1-METHYL-24- DIOXO-137-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3- THIOPHENECARBOXYLICACID
31, 2o7nA, 0.9678, 1.07, 0.978, 180, 180, CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(35-DICHLOROPHENYL)-5-OXO-2357A-TETRAHYDRO- 1H-PYRROLO[12-A]PYRROLE-7-CARBONITRILE
32, 5e6sA, 0.9636, 1.09, 0.966, 578, 179, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
33, 5e6rA, 0.9636, 1.36, 0.961, 581, 180, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
34, 5e6uA, 0.9633, 1.34, 0.961, 583, 180, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
35, 3f74B, 0.9632, 1.17, 0.961, 180, 180, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
36, 3f78B, 0.9631, 1.18, 0.961, 180, 180, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
37, 3f78A, 0.9620, 1.20, 0.961, 180, 180, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
38, 5e6sE, 0.9618, 1.45, 0.961, 580, 180, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
39, 3f78C, 0.9608, 1.26, 0.961, 180, 179, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
40, 5e6sC, 0.9606, 1.17, 0.966, 578, 178, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
41, 3f74C, 0.9605, 1.28, 0.961, 180, 179, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
42, 3f74A, 0.9587, 1.23, 0.961, 180, 180, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
43, 1zonA, 0.9572, 1.38, 0.956, 181, 180, CD11A I-DOMAIN WITHOUT BOUND CATION
44, 1xuoB, 0.9570, 0.55, 0.989, 175, 175, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
45, 6ckbA, 0.9568, 1.35, 0.961, 464, 180, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
46, 6bxfB, 0.9539, 1.06, 0.949, 464, 178, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
47, 6bxfA, 0.9528, 1.42, 0.961, 463, 180, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
48, 6bxbA, 0.9519, 1.45, 0.961, 463, 180, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
49, 1dgqA, 0.9491, 1.30, 0.989, 188, 181, NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
50, 3qa3L, 0.9484, 1.04, 0.337, 185, 178, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
51, 1mjnA, 0.9458, 1.18, 0.921, 179, 177, CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT
52, 3qa3E, 0.9441, 1.21, 0.346, 186, 179, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
53, 6ckbB, 0.9430, 1.15, 0.966, 465, 178, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
54, 6bxbB, 0.9386, 1.23, 0.949, 465, 178, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
55, 1mf7A, 0.9380, 1.43, 0.339, 194, 180, INTEGRIN ALPHA M I DOMAIN
56, 3qa3G, 0.9372, 1.37, 0.335, 187, 179, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
57, 3qa3I, 0.9340, 1.45, 0.337, 185, 178, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
58, 3q3gL, 0.9337, 1.41, 0.341, 189, 179, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
59, 3q3gI, 0.9317, 1.52, 0.350, 189, 180, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
60, 1na5A, 0.9314, 1.51, 0.339, 195, 180, INTEGRIN ALPHA M I DOMAIN
61, 3q3gE, 0.9313, 1.52, 0.350, 189, 180, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
62, 3q3gG, 0.9301, 1.53, 0.350, 189, 180, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
63, 1jlmA, 0.9297, 1.47, 0.341, 187, 179, I-DOMAIN FROM INTEGRIN CR3 MN2+ BOUND
64, 5es4A, 0.9275, 1.62, 0.370, 1080, 181, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
65, 1n3yA, 0.9252, 1.61, 0.367, 189, 180, CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN
66, 1idn1, 0.9242, 1.52, 0.352, 189, 179, MAC-1 I DOMAIN METAL FREE
67, 1bhq1, 0.9239, 1.54, 0.352, 189, 179, MAC-1 I DOMAIN CADMIUM COMPLEX
68, 1bho1, 0.9237, 1.54, 0.352, 189, 179, MAC-1 I DOMAIN MAGNESIUM COMPLEX
69, 1idn2, 0.9236, 1.56, 0.352, 189, 179, MAC-1 I DOMAIN METAL FREE
70, 1bho2, 0.9222, 1.58, 0.352, 189, 179, MAC-1 I DOMAIN MAGNESIUM COMPLEX
71, 1bhq2, 0.9214, 1.58, 0.352, 189, 179, MAC-1 I DOMAIN CADMIUM COMPLEX
72, 3k71G, 0.9176, 1.64, 0.367, 1082, 180, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
73, 3k6sA, 0.9171, 1.65, 0.367, 1082, 180, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
74, 3tcxD, 0.9130, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
75, 3tcxT, 0.9128, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
76, 3tcxL, 0.9128, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
77, 3tcxF, 0.9128, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
78, 3tcxB, 0.9128, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
79, 3tcxZ, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
80, 3tcxR, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
81, 3tcxN, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
82, 3tcxJ, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
83, 3tcxH, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
84, 3tcxb, 0.9127, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
85, 3tcxV, 0.9126, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
86, 3tcxP, 0.9126, 1.57, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
87, 3tcxX, 0.9124, 1.58, 0.910, 180, 177, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
88, 3hi6A, 0.9084, 1.40, 0.931, 180, 174, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
89, 3hi6B, 0.9078, 1.41, 0.931, 180, 174, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
90, 1t0pA, 0.8959, 1.66, 0.948, 174, 173, STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A
91, 1mqaA, 0.8867, 1.90, 0.942, 174, 173, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL
92, 1mq9A, 0.8800, 2.10, 0.931, 173, 173, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT
93, 1mq8D, 0.8791, 1.81, 0.920, 177, 175, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
94, 1mq8B, 0.8790, 1.81, 0.920, 177, 175, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
95, 4dmuJ, 0.8786, 1.89, 0.216, 191, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
96, 4dmuF, 0.8783, 1.90, 0.216, 188, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
97, 4dmuD, 0.8780, 1.91, 0.216, 188, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
98, 4dmuH, 0.8776, 1.91, 0.216, 187, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
99, 4dmuB, 0.8774, 1.91, 0.216, 188, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
100, 4xw2A, 0.8773, 1.70, 0.349, 184, 172, STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT RECEPTOR 3
101, 4dmuL, 0.8773, 1.91, 0.216, 188, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
102, 1ao3A, 0.8768, 1.87, 0.227, 187, 176, A3 DOMAIN OF VON WILLEBRAND FACTOR
103, 1atzB, 0.8760, 2.02, 0.215, 189, 177, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
104, 1ao3B, 0.8747, 1.90, 0.227, 187, 176, A3 DOMAIN OF VON WILLEBRAND FACTOR
105, 4m76B, 0.8742, 1.63, 0.349, 179, 172, INTEGRIN I DOMAIN OF COMPLEMENT RECEPTOR 3 IN COMPLEX WITH C3D
106, 2adfA, 0.8719, 1.94, 0.227, 189, 176, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
107, 3bn3A, 0.8714, 1.60, 0.982, 180, 167, CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
108, 5hj2C, 0.8713, 2.26, 0.240, 197, 179, INTEGRIN ALPHA2BETA1 I-DOMAIN
109, 5hj2B, 0.8713, 2.21, 0.236, 196, 178, INTEGRIN ALPHA2BETA1 I-DOMAIN
110, 1atzA, 0.8710, 1.97, 0.227, 184, 176, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
111, 1aoxB, 0.8710, 2.25, 0.240, 201, 179, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
112, 5hj2E, 0.8708, 2.20, 0.230, 196, 178, INTEGRIN ALPHA2BETA1 I-DOMAIN
113, 1mhpB, 0.8708, 2.22, 0.236, 192, 178, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
114, 1ck4B, 0.8700, 2.24, 0.236, 194, 178, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
115, 1aoxA, 0.8694, 2.23, 0.230, 201, 178, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
116, 5hgjB, 0.8692, 2.18, 0.237, 193, 177, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
117, 1qcyA, 0.8691, 2.23, 0.236, 193, 178, THE CRYSTAL STRUCTURE OF THE I-DOMAIN OF HUMAN INTEGRIN ALPHA1BETA1
118, 1ck4A, 0.8691, 2.25, 0.236, 192, 178, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
119, 2b2xA, 0.8690, 2.19, 0.237, 188, 177, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
120, 1idoA, 0.8689, 2.01, 0.320, 184, 175, I-DOMAIN FROM INTEGRIN CR3 MG2+ BOUND
121, 5hj2D, 0.8687, 2.30, 0.240, 197, 179, INTEGRIN ALPHA2BETA1 I-DOMAIN
122, 1m1uA, 0.8673, 2.04, 0.320, 184, 175, AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
123, 1qc5A, 0.8664, 2.21, 0.232, 192, 177, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
124, 5hj2A, 0.8659, 2.33, 0.246, 196, 179, INTEGRIN ALPHA2BETA1 I-DOMAIN
125, 1n9zA, 0.8656, 1.79, 0.349, 184, 172, INTEGRIN ALPHA M I DOMAIN MUTANT
126, 5hgjA, 0.8650, 2.23, 0.237, 194, 177, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
127, 1pt6A, 0.8650, 2.22, 0.237, 192, 177, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
128, 4nehA, 0.8643, 1.97, 0.356, 1084, 174, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
129, 1qc5B, 0.8642, 2.18, 0.239, 190, 176, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
130, 4nenA, 0.8636, 1.96, 0.356, 1063, 174, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
131, 5hj2F, 0.8635, 2.25, 0.232, 195, 177, INTEGRIN ALPHA2BETA1 I-DOMAIN
132, 1v7pC, 0.8630, 2.22, 0.232, 193, 177, STRUCTURE OF EMS16-ALPHA2-I DOMAIN COMPLEX
133, 1mhpA, 0.8620, 2.13, 0.240, 184, 175, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
134, 5thpO, 0.8608, 2.15, 0.244, 191, 176, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
135, 1pt6B, 0.8595, 2.23, 0.239, 195, 176, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
136, 1fe8C, 0.8576, 2.01, 0.220, 187, 173, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
137, 5thpF, 0.8575, 2.34, 0.247, 193, 178, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
138, 4cn9B, 0.8560, 2.14, 0.247, 396, 174, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
139, 4a0qB, 0.8559, 2.35, 0.232, 192, 177, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
140, 4cn9A, 0.8553, 2.15, 0.247, 397, 174, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
141, 4cnbB, 0.8551, 2.15, 0.247, 391, 174, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
142, 1fe8A, 0.8551, 2.03, 0.220, 186, 173, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
143, 4cn8A, 0.8549, 2.15, 0.247, 392, 174, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS
144, 4cnbA, 0.8546, 2.16, 0.247, 387, 174, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
145, 1fe8B, 0.8545, 2.04, 0.220, 186, 173, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
146, 4a0qA, 0.8544, 2.28, 0.233, 187, 176, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
147, 4ihkA, 0.8537, 2.05, 0.221, 193, 172, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN R1061Q
148, 5thpR, 0.8527, 2.38, 0.233, 187, 176, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
149, 3zqkC, 0.8523, 2.13, 0.220, 178, 173, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
150, 3zqkB, 0.8523, 2.11, 0.220, 178, 173, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
151, 3ppyA, 0.8520, 2.10, 0.220, 187, 173, CRYSTAL STRUCTURE OF THE D1596A/N1602A DOUBLE MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
152, 3ppwA, 0.8515, 2.10, 0.220, 184, 173, CRYSTAL STRUCTURE OF THE D1596A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
153, 3ppxA, 0.8507, 2.12, 0.214, 184, 173, CRYSTAL STRUCTURE OF THE N1602A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
154, 5thpC, 0.8460, 2.32, 0.244, 190, 176, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
155, 4igiA, 0.8447, 2.10, 0.216, 197, 171, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN
156, 5thpL, 0.8446, 2.32, 0.234, 189, 175, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
157, 3zqkA, 0.8433, 2.19, 0.225, 181, 173, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
158, 5thpI, 0.8427, 2.38, 0.233, 191, 176, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
159, 3ppvA, 0.8382, 2.26, 0.214, 184, 173, CRYSTAL STRUCTURE OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
160, 3hxqA, 0.8278, 2.42, 0.220, 201, 173, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
161, 3hxoA, 0.8276, 2.46, 0.220, 199, 173, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
162, 2b2xB, 0.8274, 2.36, 0.271, 176, 170, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
163, 1uexC, 0.8270, 2.47, 0.220, 202, 173, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN
164, 1ijbA, 0.8261, 2.42, 0.215, 202, 172, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN
165, 4c29A, 0.8257, 2.54, 0.213, 201, 174, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
166, 3gxbB, 0.8249, 2.50, 0.209, 177, 172, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
167, 3gxbA, 0.8249, 2.51, 0.209, 177, 172, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
168, 4c29B, 0.8248, 2.54, 0.213, 201, 174, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
169, 1u0oC, 0.8248, 2.47, 0.208, 195, 173, THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX
170, 5bv8A, 0.8246, 2.49, 0.225, 209, 173, G1324S MUTATION IN VON WILLEBRAND FACTOR A1 DOMAIN
171, 1fnsA, 0.8246, 2.47, 0.220, 196, 173, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
172, 1ijkA, 0.8242, 2.51, 0.220, 199, 173, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX
173, 1oakA, 0.8239, 2.49, 0.220, 196, 173, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
174, 1u0nA, 0.8232, 2.51, 0.220, 207, 173, THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX
175, 1auqA, 0.8230, 2.51, 0.220, 208, 173, A1 DOMAIN OF VON WILLEBRAND FACTOR
176, 1sq0A, 0.8216, 2.50, 0.220, 198, 173, CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION
177, 4c2bG, 0.8207, 2.35, 0.205, 197, 171, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
178, 4c2bC, 0.8201, 2.48, 0.215, 199, 172, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
179, 4c2aA, 0.8186, 2.58, 0.220, 202, 173, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH R1306Q AND I1309V MUTATIONS IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
180, 1m10A, 0.8176, 2.56, 0.220, 199, 173, CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN
181, 4c2bE, 0.8162, 2.56, 0.208, 199, 173, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
182, 4c2bA, 0.8149, 2.43, 0.216, 199, 171, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
183, 3hs0D, 0.8097, 2.50, 0.200, 699, 170, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
184, 2x31D, 0.8094, 2.51, 0.069, 187, 174, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
185, 2ww8A, 0.8079, 2.63, 0.185, 815, 173, STRUCTURE OF THE PILUS ADHESIN (RRGA) FROM STREPTOCOCCUS PNEUMONIAE
186, 4f1kA, 0.8074, 2.60, 0.184, 200, 174, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
187, 2odpA, 0.8072, 2.59, 0.186, 490, 172, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
188, 4f1jA, 0.8068, 2.60, 0.184, 200, 174, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
189, 2odqA, 0.8060, 2.59, 0.186, 492, 172, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
190, 1dziA, 0.8060, 2.50, 0.251, 185, 171, INTEGRIN ALPHA2 I DOMAIN / COLLAGEN COMPLEX
191, 3hs0I, 0.8057, 2.61, 0.199, 704, 171, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
192, 4f1kB, 0.8055, 2.62, 0.184, 200, 174, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
193, 4f1jB, 0.8052, 2.63, 0.184, 200, 174, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
194, 2x31B, 0.8052, 2.56, 0.069, 187, 173, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
195, 2i6qA, 0.8049, 2.58, 0.186, 503, 172, COMPLEMENT COMPONENT C2A
196, 2xwjJ, 0.8042, 2.78, 0.197, 713, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
197, 4hqkB, 0.8039, 2.62, 0.190, 199, 174, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
198, 2xwjK, 0.8032, 2.77, 0.197, 713, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
199, 2x31E, 0.8028, 2.62, 0.069, 187, 174, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
200, 4bj3A, 0.8026, 2.40, 0.237, 183, 169, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
201, 4hqkA, 0.8025, 2.63, 0.190, 200, 174, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
202, 3txaA, 0.8002, 2.75, 0.172, 583, 174, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
203, 2xwjL, 0.8001, 2.80, 0.197, 711, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
204, 2xwjI, 0.7999, 2.81, 0.197, 712, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
205, 3tvyA, 0.7992, 2.76, 0.172, 365, 174, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
206, 3hrzD, 0.7989, 2.56, 0.200, 693, 170, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
207, 2x31F, 0.7981, 2.60, 0.069, 187, 173, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
208, 2x31C, 0.7977, 2.54, 0.075, 187, 173, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
209, 2x31A, 0.7972, 2.66, 0.075, 187, 174, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
210, 4bj3B, 0.7970, 2.26, 0.248, 179, 165, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
211, 2ok5A, 0.7862, 2.57, 0.204, 710, 167, HUMAN COMPLEMENT FACTOR B
212, 2m32A, 0.7851, 2.73, 0.257, 192, 171, ALPHA-1 INTEGRIN I-DOMAIN IN COMPLEX WITH GLOGEN TRIPLE HELICAL PEPTIDE
213, 4wfqA, 0.7837, 2.34, 0.139, 192, 165, CRYSTAL STRUCTURE OF TFIIH SUBUNIT
214, 2i6sA, 0.7817, 2.44, 0.188, 497, 165, COMPLEMENT COMPONENT C2A
215, 5m6wJ, 0.7815, 2.58, 0.189, 505, 169, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
216, 2winL, 0.7811, 2.76, 0.181, 507, 171, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
217, 2winK, 0.7811, 2.76, 0.181, 507, 171, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
218, 2winJ, 0.7811, 2.76, 0.181, 507, 171, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
219, 2winI, 0.7811, 2.76, 0.181, 507, 171, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
220, 2xwbH, 0.7800, 2.91, 0.198, 711, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
221, 2xwbF, 0.7800, 2.92, 0.198, 714, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
222, 5m6wL, 0.7781, 2.61, 0.189, 505, 169, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
223, 5mpbIA, 0.7740, 2.81, 0.112, 197, 170, 
224, 5mpcIA, 0.7737, 2.95, 0.100, 197, 170, 
225, 4fx5A, 0.7735, 2.68, 0.192, 415, 167, VON WILLEBRAND FACTOR TYPE A FROM CATENULISPORA ACIDIPHILA
226, 5mpeW, 0.7702, 2.75, 0.119, 197, 168, 26S PROTEASOME IN PRESENCE OF ATP (S2)
227, 5oqm6, 0.7700, 2.47, 0.146, 335, 164, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
228, 5oqj6, 0.7700, 2.47, 0.146, 335, 164, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
229, 5ln1A, 0.7687, 2.73, 0.127, 188, 165, STRUCTURE OF UBIQUITYLATED-RPN10 FROM YEAST;
230, 1rs0A, 0.7654, 2.83, 0.190, 480, 168, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
231, 5t0gb, 0.7651, 2.81, 0.101, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
232, 5t0cNA, 0.7651, 2.81, 0.101, 191, 168, 
233, 5t0cH, 0.7651, 2.81, 0.101, 191, 168, 
234, 1rrkA, 0.7651, 2.84, 0.190, 480, 168, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
235, 1rtkA, 0.7650, 2.85, 0.190, 486, 168, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
236, 5l4kW, 0.7644, 2.94, 0.088, 196, 170, THE HUMAN 26S PROTEASOME LID
237, 5vftb, 0.7639, 2.70, 0.102, 191, 167, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
238, 5t0hb, 0.7639, 2.70, 0.102, 191, 167, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
239, 4cr2W, 0.7638, 2.86, 0.112, 197, 169, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
240, 3jcpFA, 0.7622, 2.98, 0.116, 197, 172, 
241, 5kynB, 0.7619, 3.00, 0.129, 719, 170, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
242, 5kyxA, 0.7615, 2.98, 0.124, 716, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
243, 4okrB, 0.7611, 2.49, 0.181, 236, 160, STRUCTURES OF TOXOPLASMA GONDII MIC2
244, 5gjqW, 0.7609, 3.08, 0.105, 193, 172, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
245, 5gjrP, 0.7607, 3.09, 0.105, 193, 172, 
246, 5gjrJB, 0.7607, 3.09, 0.105, 193, 172, 
247, 1jeyA, 0.7601, 2.79, 0.138, 493, 167, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
248, 5vnhA, 0.7600, 3.00, 0.129, 707, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
249, 5vfsV, 0.7600, 2.93, 0.100, 191, 170, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
250, 3n2nA, 0.7600, 2.71, 0.202, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
251, 1jeqA, 0.7600, 2.78, 0.132, 548, 167, CRYSTAL STRUCTURE OF THE KU HETERODIMER
252, 3jcoFA, 0.7596, 3.00, 0.116, 197, 172, 
253, 5vniA, 0.7595, 2.94, 0.129, 707, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
254, 3n2nF, 0.7595, 2.65, 0.202, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
255, 5mpdW, 0.7594, 2.99, 0.123, 197, 171, 26S PROTEASOME IN PRESENCE OF ATP (S1)
256, 3n2nE, 0.7594, 2.69, 0.202, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
257, 5kyyA, 0.7591, 2.94, 0.129, 716, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
258, 5kywA, 0.7591, 3.00, 0.124, 714, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
259, 5vnjA, 0.7587, 2.93, 0.129, 697, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
260, 5kyuA, 0.7587, 3.00, 0.124, 716, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
261, 3n2nD, 0.7587, 2.65, 0.209, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
262, 3egdA, 0.7586, 2.97, 0.124, 711, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
263, 5wvkRA, 0.7585, 2.81, 0.113, 197, 168, 
264, 5vgzb, 0.7585, 3.01, 0.094, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
265, 3n2nB, 0.7584, 2.69, 0.202, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
266, 5vneA, 0.7581, 2.96, 0.124, 708, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
267, 3efoA, 0.7581, 3.00, 0.124, 716, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
268, 2nupA, 0.7581, 3.01, 0.124, 699, 170, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
269, 5vnoA, 0.7580, 2.94, 0.129, 703, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
270, 5vnlA, 0.7580, 2.94, 0.129, 699, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
271, 5vnmA, 0.7578, 3.01, 0.124, 698, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
272, 1jeqB, 0.7577, 3.16, 0.117, 520, 171, CRYSTAL STRUCTURE OF THE KU HETERODIMER
273, 2nutA, 0.7576, 2.94, 0.129, 708, 170, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
274, 5vnkA, 0.7575, 2.94, 0.124, 708, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
275, 3eg9A, 0.7574, 3.01, 0.124, 726, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
276, 2x5nA, 0.7573, 2.68, 0.117, 188, 163, CRYSTAL STRUCTURE OF THE SPRPN10 VWA DOMAIN
277, 5vnfA, 0.7572, 2.97, 0.124, 707, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
278, 5vnnA, 0.7571, 2.94, 0.129, 699, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
279, 1pd1A, 0.7571, 2.93, 0.101, 735, 168, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE CONTAINING THE DXE CARGO SORTING SIGNAL OF YEAST SYS1 PROTEIN
280, 5vfpU, 0.7569, 2.94, 0.100, 191, 170, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
281, 3egxA, 0.7569, 2.98, 0.124, 708, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
282, 5vngA, 0.7568, 3.01, 0.124, 696, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
283, 1pcxA, 0.7568, 2.93, 0.101, 745, 168, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1
284, 1shuX, 0.7563, 2.59, 0.160, 181, 163, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
285, 5vhfb, 0.7561, 3.05, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
286, 1pd0A, 0.7561, 2.94, 0.101, 734, 168, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN SED5 (YEAST SYNTAXIN-5)
287, 5vhhb, 0.7560, 3.05, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
288, 1jeyB, 0.7560, 3.17, 0.110, 530, 172, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
289, 5iy80, 0.7559, 2.67, 0.128, 188, 164, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
290, 5iy70, 0.7559, 2.67, 0.128, 188, 164, HUMAN HOLO-PIC IN THE OPEN STATE
291, 5iy60, 0.7559, 2.67, 0.128, 188, 164, HUMAN HOLO-PIC IN THE CLOSED STATE
292, 3n2nC, 0.7559, 2.73, 0.202, 185, 163, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
293, 5iy90, 0.7558, 2.67, 0.128, 188, 164, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
294, 5ivw0, 0.7557, 2.67, 0.128, 188, 164, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
295, 1t6bY, 0.7554, 2.34, 0.195, 170, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR
296, 5nusA, 0.7551, 2.96, 0.108, 210, 167, STRUCTURE OF A MINIMAL COMPLEX BETWEEN P44 AND P34 FROM CHAETOMIUM THERMOPHILUM
297, 3tw0B, 0.7550, 2.91, 0.167, 361, 168, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
298, 5of4E, 0.7549, 2.67, 0.116, 184, 164, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
299, 1m2vB, 0.7546, 2.94, 0.101, 748, 168, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
300, 4bziL, 0.7545, 2.95, 0.101, 735, 168, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
301, 4bziM, 0.7544, 2.95, 0.101, 735, 168, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
302, 4bziE, 0.7544, 2.95, 0.101, 735, 168, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
303, 4okuB, 0.7540, 2.48, 0.182, 241, 159, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
304, 5oqm4, 0.7537, 3.30, 0.145, 297, 173, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
305, 5oqj4, 0.7537, 3.30, 0.145, 297, 173, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
306, 3tw0C, 0.7537, 2.85, 0.167, 360, 168, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
307, 5kynA, 0.7534, 3.06, 0.129, 730, 170, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
308, 5vhsb, 0.7532, 3.07, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
309, 1m2oA, 0.7531, 3.05, 0.118, 718, 170, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
310, 3tw0A, 0.7526, 2.92, 0.167, 361, 168, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
311, 3eh2B, 0.7526, 3.00, 0.100, 739, 170, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
312, 5obzA, 0.7523, 3.08, 0.102, 200, 167, LOW RESOLUTION STRUCTURE OF THE P34CT/P44CT MINIMAL COMPLEX
313, 5o85C, 0.7523, 3.15, 0.095, 198, 168, P34-P44 COMPLEX
314, 1m2oC, 0.7521, 3.07, 0.118, 718, 170, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
315, 3eh2A, 0.7519, 3.03, 0.105, 758, 171, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
316, 5vhib, 0.7518, 3.07, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
317, 5gjvF, 0.7518, 2.91, 0.095, 941, 169, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION
318, 4bziG, 0.7517, 3.07, 0.118, 733, 170, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
319, 4bziD, 0.7517, 3.07, 0.118, 733, 170, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
320, 4bziA, 0.7517, 3.07, 0.118, 733, 170, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
321, 2qtvA, 0.7517, 3.07, 0.118, 733, 170, STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31
322, 4pn7A, 0.7514, 3.05, 0.107, 209, 168, CRYSTAL STRUCTURE OF THE TFIIH P34 N-TERMINAL DOMAIN
323, 3eg9B, 0.7513, 2.98, 0.106, 767, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
324, 1m2vA, 0.7513, 3.10, 0.118, 705, 170, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
325, 3efoB, 0.7507, 2.99, 0.106, 767, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
326, 5y3rB, 0.7505, 3.19, 0.115, 526, 174, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
327, 5kyyB, 0.7502, 2.99, 0.106, 767, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
328, 5vfqV, 0.7499, 3.08, 0.094, 191, 170, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
329, 3tw0D, 0.7497, 2.77, 0.163, 357, 166, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
330, 5vfuH, 0.7492, 3.03, 0.095, 191, 168, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
331, 5t0ib, 0.7492, 3.03, 0.095, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
332, 5kyxB, 0.7490, 3.01, 0.106, 767, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
333, 4cr4W, 0.7490, 3.15, 0.105, 197, 171, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
334, 5gjwF, 0.7486, 2.93, 0.101, 941, 169, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP
335, 1tzno, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
336, 1tznm, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
337, 1tznl, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
338, 1tznk, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
339, 1tznj, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
340, 1tzni, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
341, 1tznh, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
342, 1tzng, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
343, 1tznf, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
344, 1tzne, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
345, 1tznd, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
346, 1tznc, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
347, 1tznb, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
348, 1tzna, 0.7486, 2.67, 0.166, 181, 163, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
349, 1shtX, 0.7484, 2.72, 0.160, 177, 163, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
350, 3jbrF, 0.7482, 2.98, 0.112, 872, 170, CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM
351, 3ze2D, 0.7477, 2.86, 0.152, 367, 165, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
352, 5t0jb, 0.7472, 3.05, 0.095, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
353, 4hqoB, 0.7472, 3.00, 0.178, 260, 169, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
354, 5kyuB, 0.7471, 3.02, 0.106, 764, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
355, 5kywB, 0.7468, 3.02, 0.106, 766, 170, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
356, 5iy73, 0.7446, 2.97, 0.103, 193, 165, HUMAN HOLO-PIC IN THE OPEN STATE
357, 5iy63, 0.7446, 2.97, 0.103, 193, 165, HUMAN HOLO-PIC IN THE CLOSED STATE
358, 5iy93, 0.7444, 2.97, 0.103, 193, 165, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
359, 5iy83, 0.7444, 2.97, 0.103, 193, 165, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
360, 1tyeF, 0.7441, 2.88, 0.145, 440, 165, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
361, 5ivw3, 0.7435, 2.98, 0.109, 193, 165, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
362, 3eh2C, 0.7435, 3.10, 0.106, 739, 170, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
363, 2vc2B, 0.7431, 2.90, 0.152, 457, 165, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
364, 2vdoB, 0.7430, 2.90, 0.145, 455, 165, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
365, 3fcuF, 0.7428, 2.90, 0.145, 455, 165, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
366, 3fcuD, 0.7426, 2.91, 0.152, 455, 165, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
367, 2vdnB, 0.7424, 2.91, 0.152, 455, 165, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
368, 2vdrB, 0.7423, 2.89, 0.158, 455, 165, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
369, 3fcuB, 0.7422, 2.92, 0.145, 455, 165, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
370, 2vdlB, 0.7421, 2.89, 0.158, 456, 165, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
371, 2vdpB, 0.7420, 2.91, 0.152, 455, 165, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
372, 2vdkB, 0.7419, 2.92, 0.145, 455, 165, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
373, 1tyeD, 0.7419, 2.89, 0.152, 440, 165, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
374, 2vdqB, 0.7418, 2.89, 0.158, 455, 165, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
375, 6epdW, 0.7417, 3.02, 0.114, 195, 167, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
376, 4hqnB, 0.7417, 3.05, 0.178, 256, 169, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
377, 6epcW, 0.7414, 3.09, 0.102, 195, 167, GROUND STATE 26S PROTEASOME (GS2)
378, 1tyeB, 0.7414, 2.92, 0.152, 440, 165, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
379, 5ffoF, 0.7410, 2.88, 0.182, 242, 165, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
380, 2nutB, 0.7410, 3.01, 0.125, 729, 168, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
381, 2vdmB, 0.7407, 2.90, 0.158, 456, 165, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
382, 5ffoB, 0.7404, 2.89, 0.182, 242, 165, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
383, 4hqlB, 0.7402, 3.06, 0.178, 256, 169, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
384, 6epeW, 0.7401, 3.12, 0.089, 195, 169, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
385, 5ln3W, 0.7399, 2.88, 0.110, 185, 163, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
386, 3egdB, 0.7395, 3.04, 0.130, 731, 169, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
387, 5vnjB, 0.7393, 3.03, 0.131, 731, 168, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
388, 5wviT, 0.7392, 3.08, 0.112, 197, 169, 
389, 5vnnB, 0.7390, 3.04, 0.124, 731, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
390, 5vnoB, 0.7389, 3.02, 0.125, 731, 168, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
391, 4hqoA, 0.7389, 3.10, 0.178, 257, 169, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
392, 5a8jA, 0.7388, 2.99, 0.193, 365, 161, CRYSTAL STRUCTURE OF THE ARNB PARALOG VWA2 FROM SULFOLOBUS ACIDOCALDARIUS
393, 5y58E, 0.7387, 3.27, 0.133, 548, 173, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
394, 5vnfB, 0.7387, 3.03, 0.124, 729, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
395, 5of4F, 0.7387, 3.16, 0.118, 205, 169, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
396, 5vnlB, 0.7384, 3.04, 0.124, 731, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
397, 5vniB, 0.7384, 3.03, 0.125, 727, 168, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
398, 2iueA, 0.7383, 2.91, 0.171, 212, 164, PACTOLUS I-DOMAIN: FUNCTIONAL SWITCHING OF THE ROSSMANN FOLD
399, 5vnkB, 0.7381, 3.04, 0.130, 729, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
400, 5y58A, 0.7379, 3.28, 0.133, 548, 173, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
401, 5vnmB, 0.7379, 3.05, 0.124, 731, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
402, 5vnhB, 0.7375, 3.04, 0.124, 729, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
403, 5vneB, 0.7374, 3.04, 0.124, 729, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
404, 2nupB, 0.7374, 3.04, 0.124, 731, 169, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
405, 5y58C, 0.7373, 3.27, 0.139, 548, 173, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
406, 5vngB, 0.7373, 3.05, 0.130, 728, 169, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
407, 5o85A, 0.7365, 2.79, 0.099, 190, 161, P34-P44 COMPLEX
408, 3egxB, 0.7363, 3.04, 0.124, 729, 169, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
409, 4hqnA, 0.7357, 3.10, 0.178, 254, 169, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
410, 1q0pA, 0.7350, 2.78, 0.195, 192, 159, A DOMAIN OF FACTOR B
411, 4hqlA, 0.7349, 3.11, 0.178, 254, 169, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
412, 5a5bW, 0.7334, 3.28, 0.106, 197, 170, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
413, 4cr3W, 0.7334, 3.28, 0.106, 197, 170, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
414, 4okrA, 0.7333, 2.66, 0.192, 235, 156, STRUCTURES OF TOXOPLASMA GONDII MIC2
415, 3eh1A, 0.7332, 3.11, 0.107, 737, 169, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24B
416, 4okuA, 0.7324, 2.76, 0.191, 240, 157, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
417, 4hqfA, 0.7323, 3.25, 0.159, 200, 170, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP I4 FORM
418, 3ibsA, 0.7301, 2.80, 0.181, 200, 160, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
419, 6epfW, 0.7283, 3.27, 0.077, 195, 168, GROUND STATE 26S PROTEASOME (GS1)
420, 3v4vB, 0.7259, 3.11, 0.146, 375, 164, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
421, 3ze1B, 0.7258, 3.09, 0.158, 464, 165, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
422, 3v4vD, 0.7258, 3.10, 0.146, 375, 164, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
423, 5vfrb, 0.7254, 3.22, 0.102, 191, 167, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
424, 3ibsB, 0.7254, 2.80, 0.182, 199, 159, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
425, 3zdzB, 0.7253, 3.11, 0.158, 464, 165, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
426, 3vi4D, 0.7253, 3.22, 0.193, 433, 166, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
427, 3v4pB, 0.7250, 3.17, 0.146, 375, 164, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
428, 3v4pD, 0.7245, 3.15, 0.146, 375, 164, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
429, 4nenB, 0.7240, 2.99, 0.161, 665, 161, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
430, 4nehB, 0.7240, 3.07, 0.178, 668, 163, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
431, 3ze0B, 0.7240, 3.13, 0.163, 465, 166, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
432, 4wk4B, 0.7238, 3.23, 0.193, 435, 166, METAL ION AND LIGAND BINDING OF INTEGRIN
433, 3ze1D, 0.7238, 3.37, 0.150, 469, 167, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
434, 4z7nB, 0.7233, 3.11, 0.158, 464, 165, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
435, 4wk2B, 0.7232, 3.22, 0.193, 427, 166, METAL ION AND LIGAND BINDING OF INTEGRIN
436, 3ze2B, 0.7232, 3.16, 0.163, 469, 166, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
437, 4mmxB, 0.7230, 3.07, 0.159, 690, 164, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
438, 4mmyB, 0.7225, 3.09, 0.158, 690, 165, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
439, 3vi4B, 0.7225, 3.19, 0.177, 431, 164, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
440, 4z7oB, 0.7224, 3.15, 0.163, 464, 166, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
441, 3ze0D, 0.7223, 3.37, 0.150, 469, 167, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
442, 3vi3B, 0.7220, 3.26, 0.187, 427, 166, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
443, 3vi3D, 0.7215, 3.25, 0.187, 432, 166, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
444, 3zdzD, 0.7202, 3.39, 0.150, 469, 167, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
445, 5hdbB, 0.7201, 3.29, 0.156, 466, 167, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
446, 4um9D, 0.7197, 3.40, 0.168, 455, 167, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
447, 4um9B, 0.7197, 3.39, 0.168, 448, 167, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
448, 5netB, 0.7191, 3.27, 0.169, 448, 166, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
449, 5nerB, 0.7191, 3.27, 0.169, 448, 166, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
450, 5nemB, 0.7191, 3.27, 0.169, 448, 166, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
451, 3zdyB, 0.7191, 3.17, 0.157, 464, 166, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
452, 4z7oD, 0.7190, 3.30, 0.151, 469, 166, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
453, 4g1eB, 0.7190, 3.30, 0.150, 709, 167, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
454, 3zdyD, 0.7190, 3.31, 0.150, 469, 167, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
455, 1u8cB, 0.7190, 3.18, 0.157, 599, 166, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
456, 4z7qD, 0.7189, 3.32, 0.156, 471, 167, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
457, 4g1mB, 0.7188, 3.20, 0.157, 692, 166, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
458, 4z7qB, 0.7187, 3.31, 0.156, 466, 167, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
459, 3t3mB, 0.7186, 3.18, 0.157, 466, 166, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
460, 4wjkB, 0.7185, 3.29, 0.187, 424, 166, METAL ION AND LIGAND BINDING OF INTEGRIN
461, 4mmzB, 0.7185, 3.30, 0.144, 690, 167, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
462, 3zdxB, 0.7184, 3.19, 0.157, 464, 166, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
463, 3nidB, 0.7184, 3.19, 0.157, 466, 166, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
464, 1jv2B, 0.7184, 3.17, 0.157, 539, 166, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
465, 3nifB, 0.7183, 3.19, 0.157, 466, 166, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
466, 1l5gB, 0.7183, 3.13, 0.164, 539, 165, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
467, 3nigB, 0.7180, 3.19, 0.157, 466, 166, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
468, 3ijeB, 0.7180, 3.26, 0.156, 695, 167, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
469, 5hdbD, 0.7179, 3.34, 0.156, 471, 167, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
470, 3zdxD, 0.7179, 3.32, 0.150, 469, 167, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
471, 4z7nD, 0.7177, 3.40, 0.150, 469, 167, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
472, 1m1xB, 0.7177, 3.20, 0.163, 539, 166, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
473, 3t3pB, 0.7175, 3.20, 0.157, 466, 166, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
474, 3nidD, 0.7175, 3.23, 0.169, 471, 166, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
475, 3t3mD, 0.7174, 3.33, 0.156, 471, 167, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
476, 3t3pD, 0.7172, 3.34, 0.150, 471, 167, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
477, 5ffgB, 0.7169, 3.27, 0.169, 248, 166, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
478, 3nigD, 0.7169, 3.35, 0.150, 471, 167, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
479, 3fcsB, 0.7168, 3.33, 0.150, 680, 167, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
480, 3fcsD, 0.7164, 3.34, 0.156, 603, 167, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
481, 4wk0B, 0.7162, 3.23, 0.189, 427, 164, METAL ION AND LIGAND BINDING OF INTEGRIN
482, 3nifD, 0.7161, 3.34, 0.156, 467, 167, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
483, 6djpB, 0.7150, 3.30, 0.162, 353, 167, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
484, 4o02B, 0.7149, 3.26, 0.144, 687, 167, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
485, 4um8B, 0.7144, 3.42, 0.162, 423, 167, CRYSTAL STRUCTURE OF ALPHA V BETA 6
486, 5es4H, 0.7141, 3.06, 0.168, 674, 161, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
487, 5es4F, 0.7135, 3.16, 0.184, 674, 163, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
488, 5es4B, 0.7132, 3.14, 0.184, 674, 163, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
489, 4um8D, 0.7132, 3.47, 0.173, 414, 168, CRYSTAL STRUCTURE OF ALPHA V BETA 6
490, 5e6rB, 0.7127, 3.40, 0.163, 454, 166, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
491, 5e6uB, 0.7124, 3.33, 0.159, 453, 164, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
492, 5e6sB, 0.7114, 3.41, 0.139, 455, 165, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
493, 5es4D, 0.7113, 3.14, 0.167, 674, 162, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
494, 5e6sF, 0.7111, 3.13, 0.161, 455, 161, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
495, 6avuB, 0.7107, 3.31, 0.156, 461, 167, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
496, 3k71F, 0.7104, 3.37, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
497, 3k71D, 0.7104, 3.37, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
498, 5y58B, 0.7102, 3.26, 0.111, 568, 162, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
499, 3k72B, 0.7102, 3.37, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2
500, 3k72D, 0.7100, 3.33, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2
501, 5e6sD, 0.7099, 3.14, 0.161, 455, 161, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
502, 3k71H, 0.7098, 3.33, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
503, 3k71B, 0.7098, 3.33, 0.176, 673, 165, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
504, 5y58D, 0.7096, 3.28, 0.111, 560, 162, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
505, 6avrB, 0.7095, 3.32, 0.162, 685, 167, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
506, 6avqB, 0.7095, 3.32, 0.162, 688, 167, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
507, 5y58F, 0.7095, 3.27, 0.111, 565, 162, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
508, 3k6sH, 0.7090, 3.31, 0.176, 674, 165, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
509, 3k6sF, 0.7090, 3.31, 0.176, 674, 165, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
510, 3k6sD, 0.7090, 3.31, 0.176, 674, 165, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
511, 3k6sB, 0.7090, 3.31, 0.176, 674, 165, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
512, 5neuB, 0.7088, 3.24, 0.199, 448, 166, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
513, 4jduA, 0.7073, 3.21, 0.158, 193, 158, THE CRYSTAL STRUCTURE OF AN AEROTOLERANCE-RELATED MEMBRANE PROTEIN FROM BACTEROIDES FRAGILIS NCTC 9343 WITH MULTIPLE MUTATIONS TO SERINES.
514, 5y59B, 0.7011, 3.06, 0.127, 188, 157, CRYSTAL STRUCTURE OF KU80 AND SIR4
515, 4cakB, 0.6992, 3.43, 0.151, 680, 166, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
516, 5y3rA, 0.6963, 3.25, 0.123, 493, 162, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
517, 6cetD, 0.6673, 3.71, 0.140, 901, 164, CRYO-EM STRUCTURE OF GATOR1
518, 6cesD, 0.6654, 3.73, 0.145, 901, 165, CRYO-EM STRUCTURE OF GATOR1-RAG
519, 2xggA, 0.6271, 2.40, 0.197, 147, 132, STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 2 A_I DOMAIN
520, 2xggB, 0.6257, 2.62, 0.194, 148, 134, STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 2 A_I DOMAIN
